Orion Diagnostica's new Collagen Intact Pinp radioimmunoassay's (RIA) for type I collagen:
This article was originally published in Clinica
Orion Diagnostica (Finland) has released its new Collagen Intact PINP radioimmunoassay (RIA) for in vitro quantitative measurement of intact type I procollagen N-terminal propeptide in human serum. The assay, indicated for use in monitoring type I collagen formation, is not affected by small molecular weight degradation products of the propeptide, the company claims. The company has also released its new Collagen Rat-ICTP RIA, developed for in vitro measurement of type I collagen C-terminal cross-linked telopeptide in rat samples. The RIA is designed for use in the preclinical monitoring of therapies targeting bone-degrading diseases.